Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 25, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Uy Ear Reiterated (ARQT) at Strong Buy and Held Target at $57 on, Sep 25th, 2023
Uy Ear of Mizuho, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $57 on, Sep 25th, 2023.
Uy has made no other calls on ARQT in the last 4 months.
There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 0 agree with Uy's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Uy
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Tuesday, August 22nd, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Thursday, August 10th, 2023
- Ken Cacciatore of "TD Cowen" Maintained at Buy with Decreased Target to $50 on, Wednesday, August 9th, 2023
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $40 on, Friday, May 26th, 2023
